It is thus possible that ECM remodeling occurring upon stiffening in Mesenchymal HGSOC would lead to MEK activation and contribute to the aggressiveness of this subtype of ovarian cancer. This evidence concerns the gene MAP2K7 and ovarian carcinoma.